• 13 Hits
  • 検索条件 : 絞込み (MeSH = Antibodies, Monoclonal, Humanized / pharmacology*)
生物種 リソース名 タイトル
ヒト・動物細胞 HL60(RCB0041) Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin.
遺伝子材料 Genome Network Project Human cDNA Clone , IRAK090O06 (HGY036342) , pEF-BOS-anti human CD271-#16 (RDB20193) Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells.
ヒト・動物細胞 MCF7(RCB1904) Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
ヒト・動物細胞 ACC-MESO-1(RCB2292) Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
ヒト・動物細胞 Ba/F3(RCB0805) Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.
ヒト・動物細胞 PK-1(RCB1972) Pan-HER-An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand-induced EGFR homo- and heterodimers.
ヒト・動物細胞 293T(RCB2202) Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia.
ヒト・動物細胞 K562 , HeLa , COS-7(RCB0539) Synergistic cytotoxicity of afatinib and cetuximab against EGFR T790M involves Rab11-dependent EGFR recycling.
ヒト・動物細胞 HSC-3(RCB1975) , HSC-4(RCB1902) , SAS(RCB1974) Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.
ヒト・動物細胞 KP4(RCB1005) Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
ヒト・動物細胞 TUHR3TKB(RCB1187) , TUHR4TKB(RCB1198) Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
ヒト・動物細胞 MDA-MB-453(RCB1192) Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.
ヒト・動物細胞 JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.